We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.2B
AUM Growth
-$263M
(-1.3%)
Cap. Flow
-$7.33B
Cap. Flow
% of AUM
-36.25%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
1,198
New
79
Increased
132
Reduced
140
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$40.2M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$34.5M |
| 3 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$33.8M |
| 4 |
TSMC
TSM
|
+$26.4M |
| 5 |
Aptiv
APTV
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APTV.PRA
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
|
+$97.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$46.6M |
| 3 |
Microsoft
MSFT
|
+$40.9M |
| 4 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$39.1M |
| 5 |
NVIDIA
NVDA
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.45% |
| 2 | Financials | 8.59% |
| 3 | Healthcare | 8.3% |
| 4 | Consumer Discretionary | 6.53% |
| 5 | Industrials | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Harrow
HROW
$1.4B
| $945K | ﹤0.01% |
+49,608
| New | +$1.09M |
|
502
Axsome Therapeutics
AXSM
$12.3B
| $917K | ﹤0.01% |
+12,755
| New | +$941K |
|
503
Ligand Pharmaceuticals
LGND
$5.96B
| $910K | ﹤0.01% |
12,619
-11,077
| -47% | -$831K |
|
504
iShares Core US Aggregate Bond ETF
AGG
$138B
| $892K | ﹤0.01% |
9,105
-165
| -2% | -$16.3K |
|
|
IRBT
505
CALL
DELISTED
iRobot
IRBT
| $890K | ﹤0.01% |
+20,400
| New | +$814K |
|
|
WWE
506
DELISTED
World Wrestling Entertainment
WWE
| $868K | ﹤0.01% |
8,005
| – | – |
|
507
Alibaba
BABA
$276B
| $847K | ﹤0.01% |
10,165
+83
| +0.8% | +$7.26K |
|
508
TELA Bio
TELA
$29.1M
| $841K | ﹤0.01% |
83,054
+66,214
| +393% | +$677K |
|
509
ORIX
IX
$43.9B
| $828K | ﹤0.01% |
45,415
| – | – |
|
510
Shinhan Financial Group
SHG
$33.6B
| $820K | ﹤0.01% |
31,449
-61
| -0.2% | -$1.62K |
|
511
Flywire
FLYW
$1.99B
| $801K | ﹤0.01% |
+25,790
| New | +$773K |
|
512
Amdocs
DOX
$5.64B
| $791K | ﹤0.01% |
7,999
+1,639
| +26% | +$154K |
|
513
Southland Holdings Warrants
SLND.WS
$1.54M
| $788K | ﹤0.01% |
750,000
| – | – |
|
514
Manhattan Associates
MANH
$9.42B
| $769K | ﹤0.01% |
+3,849
| New | +$668K |
|
515
Flex
FLEX
$42.5B
| $732K | ﹤0.01% |
35,166
| – | – |
|
516
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $701K | ﹤0.01% |
29,628
-1,551
| -5% | -$35K |
|
517
Credicorp
BAP
$31.1B
| $693K | ﹤0.01% |
4,697
| – | – |
|
518
Innodata
INOD
$1.94B
| $687K | ﹤0.01% |
+60,634
| New | +$564K |
|
519
Xenon Pharmaceuticals
XENE
$6.36B
| $679K | ﹤0.01% |
+17,637
| New | +$701K |
|
520
Lattice Semiconductor
LSCC
$16.8B
| $678K | ﹤0.01% |
7,061
+2,666
| +61% | +$229K |
|
|
RVNC
521
DELISTED
Revance Therapeutics, Inc.
RVNC
| $631K | ﹤0.01% |
24,923
+16,811
| +207% | +$524K |
|
|
FORLU
522
DELISTED
Four Leaf Acquisition Corp Unit
FORLU
| $625K | ﹤0.01% |
60,000
| – | – |
|
523
DoubleVerify
DV
$1.68B
| $606K | ﹤0.01% |
15,570
| – | – |
|
524
Arteris
AIP
$1.4B
| $591K | ﹤0.01% |
+86,605
| New | +$468K |
|
525
Emcor
EME
$33B
| $588K | ﹤0.01% |
3,180
| – | – |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Calamos Advisors held 1,198 positions worth $20.2B, down 1.3% from $20.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $7.33B in Q2 2023, closing 199 positions and reducing 140 holdings. Its most notable exit was Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares, an estimated $97.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in PDC Energy, Inc. worth $36.3M.
- Calamos Advisors's largest Q2 2023 buy was PDC Energy, Inc.: 510,000 shares worth $36.3M.
- Calamos Advisors added most to Magellan Midstream Partners, L.P. in Q2 2023, an estimated $40.2M increase.
- Calamos Advisors's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $46.6M.
- Calamos Advisors fully exited Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares in Q2 2023, selling an estimated $97.5M.
- Calamos Advisors's ten largest holdings make up 20% of its $20.2B portfolio in Q2 2023.
- Calamos Advisors opened 79 new positions and closed 199 in Q2 2023.
- Calamos Advisors's portfolio value fell 1.3% quarter-over-quarter to $20.2B.
Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.